Gun + Partners: Turkey: Use Of Hemp In Production Of Pharmaceuticals

Hemp cultivation in Türkiye came to the forefront with the “Symposium on Local Governments in the Presidential Government System”…

Hemp cultivation in Türkiye came to the forefront with the “Symposium on Local Governments in the Presidential Government System” held on 9 January 2019, followed by the preparation of the “Report and Action Plan on Industrial Hemp Cultivation in Türkiye”. The hemp cultivation reached a significant stage with the publication of the Law on Amendments to the Forestry Law and Certain Laws on 5 April 2025. This law encourages the production of fibre, seeds, and stems, with the permission of the Ministry of Agriculture and Forestry.

As of 2024, Türkiye has undergone a significant regulatory change in the field of hemp cultivation and the production of pharmaceutical active ingredients. The Regulation on Hemp Cultivation and Control for the Purpose of Pharmaceutical Active Ingredient Production, published on 13 September 2024, not only regulates hemp cultivation but also encompasses the oversight of every stage of the production process. This regulation introduces a comprehensive application and approval process for individuals and legal entities wishing to engage in hemp cultivation. Furthermore, universities conducting scientific research and Ministry research institutes must obtain the necessary research permits before cultivating cannabis.

The regulation aims to ensure that hemp cultivation and the production of pharmaceutical active ingredients are carried out safely and under supervision. The control of hemp production is reinforced with measures that support the proper conduct of scientific research regarding health claims and the use of hemp in drug production. Moreover, in all licensing and application processes, coordination among the relevant institutions ensures the prevention of misuse and illegal activities related to hemp. With these regulations, Türkiye is not only increasing the use of cannabis for pharmaceutical active ingredient production but also taking an important step in scientific research and treatment.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

https://www.mondaq.com/turkey/cannabis/1590476/use-of-hemp-in-production-of-pharmaceuticals

Top 200 Cannabis Lawyers

We Support

Cannabis Law Journal – Contributing Authors

Editor – Sean Hocking

Author Bios

Canada
Matt Maurer – Minden Gross
Jeff Hergot – Wildboer Dellelce LLP

Costa Rica
Tim Morales – The Cannabis Industry Association Costa Rica

Nicaragua
Elvin Rodríguez Fabilena

USA

General
Julie Godard
Carl L Rowley -Thompson Coburn LLP

Arizona
Jerry Chesler – Chesler Consulting

California
Ian Stewart – Wilson Elser Moskowitz Edelman & Dicker LLP
Otis Felder – Wilson Elser Moskowitz Edelman & Dicker LLP
Lance Rogers – Greenspoon Marder – San Diego
Jessica McElfresh -McElfresh Law – San Diego
Tracy Gallegos – Partner – Fox Rothschild

Colorado
Adam Detsky – Knight Nicastro
Dave Rodman – Dave Rodman Law Group
Peter Fendel – CMR Real Estate Network
Nate Reed – CMR Real Estate Network

Florida
Matthew Ginder – Greenspoon Marder
David C. Kotler – Cohen Kotler

Illinois
William Bogot – Fox Rothschild

Massachusetts
Valerio Romano, Attorney – VGR Law Firm, PC

Nevada
Neal Gidvani – Snr Assoc: Greenspoon Marder
Phillip Silvestri – Snr Assoc: Greenspoon Marder

Tracy Gallegos – Associate Fox Rothschild

New Jersey

Matthew G. Miller – MG Miller Intellectual Property Law LLC
Daniel T. McKillop – Scarinci Hollenbeck, LLC

New York
Gregory J. Ryan, Esq. Tesser, Ryan & Rochman, LLP
Tim Nolen Tesser, Ryan & Rochman, LLP
Cadwalader, Wickersham & Taft LLP

Oregon
Paul Loney & Kristie Cromwell – Loney Law Group
William Stewart – Half Baked Labs

Pennsylvania
Andrew B. Sacks – Managing Partner Sacks Weston Diamond
William Roark – Principal Hamburg, Rubin, Mullin, Maxwell & Lupin
Joshua Horn – Partner Fox Rothschild

Washington DC
Teddy Eynon – Partner Fox Rothschild